These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 16296755

  • 1. Targeted delivery across the blood-brain barrier.
    Gaillard PJ, Visser CC, de Boer AG.
    Expert Opin Drug Deliv; 2005 Mar; 2(2):299-309. PubMed ID: 16296755
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
    Hui EK, Boado RJ, Pardridge WM.
    Mol Pharm; 2009 Mar; 6(5):1536-43. PubMed ID: 19624167
    [Abstract] [Full Text] [Related]

  • 6. Drug targeting. Breaking down barriers.
    Miller G.
    Science; 2002 Aug 16; 297(5584):1116-8. PubMed ID: 12183610
    [No Abstract] [Full Text] [Related]

  • 7. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT.
    Cancer Lett; 2007 Aug 28; 254(1):11-29. PubMed ID: 17275180
    [Abstract] [Full Text] [Related]

  • 8. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake.
    Chung NS, Wasan KM.
    Adv Drug Deliv Rev; 2004 May 07; 56(9):1315-34. PubMed ID: 15109771
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies.
    Walus LR, Pardridge WM, Starzyk RM, Friden PM.
    J Pharmacol Exp Ther; 1996 May 07; 277(2):1067-75. PubMed ID: 8627518
    [Abstract] [Full Text] [Related]

  • 11. Blood-brain barrier delivery.
    Pardridge WM.
    Drug Discov Today; 2007 Jan 07; 12(1-2):54-61. PubMed ID: 17198973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Strategy for effective brain drug delivery.
    Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M.
    Eur J Pharm Sci; 2010 Aug 11; 40(5):385-403. PubMed ID: 20497904
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Production and characterization of fusion proteins containing transferrin and nerve growth factor.
    Park E, Starzyk RM, McGrath JP, Lee T, George J, Schutz AJ, Lynch P, Putney SD.
    J Drug Target; 1998 Aug 11; 6(1):53-64. PubMed ID: 9769021
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro.
    Candela P, Gosselet F, Miller F, Buee-Scherrer V, Torpier G, Cecchelli R, Fenart L.
    Endothelium; 2008 Aug 11; 15(5-6):254-64. PubMed ID: 19065317
    [Abstract] [Full Text] [Related]

  • 18. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ, Zhang Y, Zhang Y, Pardridge WM.
    Biotechnol Bioeng; 2007 Feb 01; 96(2):381-91. PubMed ID: 16937408
    [Abstract] [Full Text] [Related]

  • 19. Megalin mediates the transport of leptin across the blood-CSF barrier.
    Dietrich MO, Spuch C, Antequera D, Rodal I, de Yébenes JG, Molina JA, Bermejo F, Carro E.
    Neurobiol Aging; 2008 Jun 01; 29(6):902-12. PubMed ID: 17324488
    [Abstract] [Full Text] [Related]

  • 20. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A, Stolnik S, Illum L.
    Int J Pharm; 2009 Sep 08; 379(1):146-57. PubMed ID: 19555750
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.